NO20072832L - Smertestillende middel - Google Patents
Smertestillende middelInfo
- Publication number
- NO20072832L NO20072832L NO20072832A NO20072832A NO20072832L NO 20072832 L NO20072832 L NO 20072832L NO 20072832 A NO20072832 A NO 20072832A NO 20072832 A NO20072832 A NO 20072832A NO 20072832 L NO20072832 L NO 20072832L
- Authority
- NO
- Norway
- Prior art keywords
- analgesic
- painkiller
- pain
- nitrogen
- heterocyclic group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Det beskrives et analgetikum som kan anvendes mot et vidt spektrum av smerte av forskjellige opprinnelser. Det beskrevne analgetikum omfatter som effektiv bestanddel et spesifikt morfinanderivat med en nitrogenholdig, heterosyklisk gruppe, for eksempel forbindelse (I):
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004320583 | 2004-11-04 | ||
PCT/JP2005/020297 WO2006049248A1 (ja) | 2004-11-04 | 2005-11-04 | 鎮痛剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20072832L true NO20072832L (no) | 2007-08-01 |
Family
ID=36319248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20072832A NO20072832L (no) | 2004-11-04 | 2007-06-04 | Smertestillende middel |
Country Status (13)
Country | Link |
---|---|
US (1) | US8470845B2 (no) |
EP (1) | EP1820505A4 (no) |
JP (1) | JP4706636B2 (no) |
KR (1) | KR101285645B1 (no) |
CN (1) | CN101090722B (no) |
AR (1) | AR053098A1 (no) |
CA (1) | CA2586181C (no) |
HK (1) | HK1115808A1 (no) |
MX (1) | MX2007005336A (no) |
NO (1) | NO20072832L (no) |
PE (1) | PE20060723A1 (no) |
TW (1) | TW200621785A (no) |
WO (1) | WO2006049248A1 (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2628971C (en) * | 2005-11-09 | 2014-02-11 | Toray Industries, Inc. | Therapeutic or prophylactic agent for functional bowel disorder |
KR20080081057A (ko) | 2005-12-21 | 2008-09-05 | 도레이 가부시끼가이샤 | 진해제 |
FR2902341B1 (fr) | 2006-06-16 | 2011-02-25 | Scras | Utilisation therapeutique simultanee, separee ou etalee dans le temps d'au moins une neurotoxine botulique, et d'au moins un derive opiace |
FR2910327B1 (fr) | 2006-12-22 | 2013-04-26 | Scras | Utilisation d'au moins une neurotoxine botulique pour traiter la douleur induite par les traitements therapeutiques du virus du sida. |
AU2008254038B2 (en) * | 2007-05-21 | 2013-01-10 | Toray Industries, Inc. | Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation |
CA2687956C (en) * | 2007-05-21 | 2015-03-31 | Toray Industries, Inc. | Method for producing pharmaceutical tablet |
JP5564943B2 (ja) * | 2007-05-21 | 2014-08-06 | 東レ株式会社 | 結晶性微粉化粒子 |
FR2930447B1 (fr) | 2008-04-25 | 2010-07-30 | Sod Conseils Rech Applic | Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur dans le cas de la neuropathie diabetique |
EP3761982A4 (en) | 2018-03-08 | 2021-12-15 | Victoria Link Ltd | TREATMENT OF DEMYELINIZATION DISEASES |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4118823B1 (no) * | 1964-02-03 | 1966-10-31 | ||
US3318886A (en) * | 1965-07-21 | 1967-05-09 | American Cyanamid Co | Substituted 7-hydroxymethyl-7, 8-dihydro-6-amino-6, 14-endoethenocodides and morphide |
NL8102558A (nl) * | 1981-05-25 | 1982-12-16 | Alcoa Nederland Bv | Lichtmast met versterking van de opening in het onderste gedeelte. |
AU666702B2 (en) * | 1992-01-23 | 1996-02-22 | Toray Industries, Inc. | Morphinan derivative and medicinal use |
AU686203B2 (en) * | 1993-07-23 | 1998-02-05 | Toray Industries, Inc. | Morphinan derivative and medicinal use |
ES2214532T3 (es) | 1995-03-03 | 2004-09-16 | Endo Pharmaceuticals Inc. | Uso de dextrorfano o dextrometorfano para el tratamiento de la incontinencia urinaria. |
KR20020012314A (ko) | 1999-07-19 | 2002-02-15 | 히라이 가쯔히꼬 | 빈뇨 혹은 요실금의 치료 또는 예방제 |
DE19939044A1 (de) * | 1999-08-18 | 2001-03-15 | Gruenenthal Gmbh | Verwendung von Morphinanderivaten als Arzneimittel |
ES2304477T3 (es) | 2000-10-31 | 2008-10-16 | Rensselaer Polytechnic Institute | Procedimiento de preparacion de compuestos con afinidad a receptores opioides. |
NZ539199A (en) * | 2002-10-09 | 2008-09-26 | Toray Industries | Remedies or preventives for urinary frequency or urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group |
JP4118824B2 (ja) | 2004-02-24 | 2008-07-16 | 株式会社日立製作所 | 優先パケットの遅延を最小化するシェーピング装置 |
JP4118826B2 (ja) | 2004-03-01 | 2008-07-16 | リオン株式会社 | 補聴器用ケースなどの製造方法及びその装置 |
KR101233289B1 (ko) | 2004-03-30 | 2013-02-14 | 도레이 카부시키가이샤 | 지양제 |
-
2005
- 2005-11-03 PE PE2005001291A patent/PE20060723A1/es not_active Application Discontinuation
- 2005-11-03 AR ARP050104603A patent/AR053098A1/es not_active Application Discontinuation
- 2005-11-03 TW TW094138512A patent/TW200621785A/zh not_active IP Right Cessation
- 2005-11-04 JP JP2006542444A patent/JP4706636B2/ja not_active Expired - Fee Related
- 2005-11-04 KR KR1020077011752A patent/KR101285645B1/ko not_active IP Right Cessation
- 2005-11-04 US US11/667,136 patent/US8470845B2/en not_active Expired - Fee Related
- 2005-11-04 EP EP05799891A patent/EP1820505A4/en not_active Withdrawn
- 2005-11-04 CA CA2586181A patent/CA2586181C/en not_active Expired - Fee Related
- 2005-11-04 CN CN200580045038XA patent/CN101090722B/zh not_active Expired - Fee Related
- 2005-11-04 MX MX2007005336A patent/MX2007005336A/es active IP Right Grant
- 2005-11-04 WO PCT/JP2005/020297 patent/WO2006049248A1/ja active Application Filing
-
2007
- 2007-06-04 NO NO20072832A patent/NO20072832L/no not_active Application Discontinuation
-
2008
- 2008-06-05 HK HK08106279.1A patent/HK1115808A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US20070299100A1 (en) | 2007-12-27 |
TW200621785A (en) | 2006-07-01 |
CN101090722B (zh) | 2011-12-21 |
JP4706636B2 (ja) | 2011-06-22 |
WO2006049248A1 (ja) | 2006-05-11 |
KR20070085436A (ko) | 2007-08-27 |
EP1820505A1 (en) | 2007-08-22 |
CA2586181A1 (en) | 2006-05-11 |
JPWO2006049248A1 (ja) | 2008-08-07 |
KR101285645B1 (ko) | 2013-07-12 |
HK1115808A1 (en) | 2008-12-12 |
MX2007005336A (es) | 2007-06-25 |
TWI356826B (no) | 2012-01-21 |
CN101090722A (zh) | 2007-12-19 |
EP1820505A4 (en) | 2010-01-20 |
AR053098A1 (es) | 2007-04-25 |
US8470845B2 (en) | 2013-06-25 |
PE20060723A1 (es) | 2006-08-29 |
CA2586181C (en) | 2012-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20072832L (no) | Smertestillende middel | |
ATE479687T1 (de) | Kinaseinhibitoren | |
WO2009001060A3 (en) | Use of compounds for preparing anti-tuberculosis agents | |
WO2005112646A3 (en) | Treatment of diet-related conditions using phospholipase-a2 inhibitors comprising indoles and related compounds | |
NO20062399L (no) | Transdermale smertestillende systemer som har redusert misbrukspotensial | |
MY146989A (en) | Kinase inhibitors | |
WO2005074603A3 (en) | Aminobenzoxazoles as therapeutic agents | |
WO2005075425A3 (en) | Substituted bisarylurea derivatives as kinase inhibitors | |
WO2005110410A3 (en) | Kinase inhibitors as therapeutic agents | |
WO2007028135A3 (en) | Imidazopyridine compounds | |
WO2007023110A3 (en) | P38 map kinase inhibitors and methods for using the same | |
WO2006066109A3 (en) | Hydroxysteroid dehydrogenase inhibitors | |
WO2008055236A3 (en) | Mapk/erk kinase inhibitors | |
EA200500203A1 (ru) | Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат | |
TW200615266A (en) | Organic compounds | |
WO2007059230A3 (en) | Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors | |
WO2007084390A3 (en) | Histone deacetylase inhibitors | |
AU2009215534A8 (en) | Compounds that are ERK inhibitors | |
NO20092692L (no) | MAPK/ERK kinaseinhibitorer | |
WO2007112014A3 (en) | New therapeutic combinations for the treatment of depression | |
NO20061818L (no) | Fremgangsmate for a inhibere remnant lipoproteinproduksjon | |
NO20064351L (no) | Caspaseinhibitorer og anvendelser derav | |
WO2007099171A3 (en) | Bicyclo-pyrazoles active as kinase inhibitors | |
GEP20166481B (en) | (crystalline forms of hydrochloride salt of (4a-r, 9a-s)-1-(1h-benzoimidazole-5-carbonyl)-2, 3, 4, 4a, 9, 9a-hexa- hydro-1h-indeno [2, 1-b] pyridine-6-carbonitrile and their use as hsd 1 inhibitors | |
WO2009051223A1 (ja) | 白内障処置のための医薬組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |